Dark

IBRX
ImmunityBio, Inc. Common Stock
stock NASDAQ

At Close

Dec 5, 2025 3:59:56 PM EST

2.29USD-0.435%(-0.01)6,845,958

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 5, 2025 9:25:30 AM EST

2.30USD0.000%(0.00)66,110

After-hours

Dec 5, 2025 4:53:30 PM EST

2.30USD+0.437%(+0.01)14,637

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

2.25B

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Mar 2, 2026 (86d)

IBRX Stats

Avg. Vol. 10 Day

12,370,034

Avg. Vol. 30 Day

10,194,165

Employees

703

Market Cap

2,250,645,434

Shares Out.

984,965,179

On/Off Exchange

43%/57%

6 Month Beta

2.42

1 Year Beta

1.57

2 Year Beta

1.74

3 Year Beta

2.03

52 Week Low

1.83

52 Week High

5.12

SMA50

2.32

SMA200

2.60

1 Week

-3.18%

1 Month

+7.78%

3 Month

-4.79%

6 Month

-27.46%

1 Year

-53.93%

2 Year

-38.58%

5 Year

-78.63%

Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.

IBRX Stock Summary

ImmunityBio, Inc. Common Stock (NASDAQ:IBRX) stock price today is $2.29, and today's volume is 6,845,958. IBRX is down -0.435% today. The 30 day average volume is 10,194,165. IBRX market cap is 2.25B with 984,965,179 shares outstanding.

.dark-mode .dnjrHv{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .dnjrHv{ color: #333333; background-color: white; border: 2px solid #333333; }IBRXImmunityBio, Inc. Common Stockstock NASDAQ

IBRX Stock Summary

IBRX
ImmunityBio, Inc. Common Stock
stock NASDAQ